Related Experiment Video

Updated: Mar 31, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

Corrigendum: Whole-genome characterization of chemoresistant ovarian cancer

Ann-Marie Patch, Elizabeth L Christie, Dariush Etemadmoghadam

    Nature
    |October 28, 2015
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
    11:50

    Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

    Published on: September 10, 2014

    14.0K
    Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
    09:40

    Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

    Published on: August 2, 2024

    3.3K

    Related Experiment Videos

    Last Updated: Mar 31, 2026

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    8.1K
    Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
    11:50

    Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

    Published on: September 10, 2014

    14.0K
    Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
    09:40

    Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

    Published on: August 2, 2024

    3.3K

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    3.9K
    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.9K
    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    1.5K
    1.5K
    Cancer-Critical Genes II: Tumor Suppressor Genes01:05

    Cancer-Critical Genes II: Tumor Suppressor Genes

    3.0K
    3.0K
    Cancer-Critical Genes II: Tumor Suppressor Genes01:05

    Cancer-Critical Genes II: Tumor Suppressor Genes

    10.1K
    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    10.1K

    Articles linked to this work by shared authors, journal, and citation graph.

    Real-World Experience of Cabozantinib in Relapsed Osteosarcoma and Ewing Sarcoma-A Single Center Retrospective Study.

    Asia-Pacific journal of clinical oncology·2026

    Digital Vaginal and Ultrasound Assessments and the Likelihood of Intrapartum Cesarean Delivery: A Prognostic Factor Study.

    Ultraschall in der Medizin (Stuttgart, Germany : 1980)·2026

    Polymeric microneedle patches for rapid DNA extraction and molecular diagnosis of foliar pathogens of mung bean.

    Talanta·2026

    Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium.

    British journal of cancer·2026

    Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

    Nature communications·2026

    Compounding or confounding?-addressing context-specific disparities in access to outpatient specialty palliative care.

    Annals of palliative medicine·2026

    Population-scale immune multiome atlas reveals regulatory disease mechanisms.

    Nature·2026

    A TBK1/ULK1 signalling axis couples lysosomal stress to TFEB activation.

    Nature·2026

    Type 2 immune history trains lung macrophages for viral disease tolerance.

    Nature·2026

    Sugar-rich foods exacerbate antibiotic-induced microbiome disruption.

    Nature·2026

    Osteoclasts intercept meningeal lymphatic paths for dural metastasis.

    Nature·2026

    Self-aligned optical microcomb emerging between octave-separated lasers.

    Nature·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us